Can cannabis ease opioid withdrawal? small study aims to find out
NCT ID NCT05729932
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study is testing whether inhaled cannabis can reduce withdrawal symptoms in people with opioid use disorder who are not currently seeking treatment. Researchers will give participants either cannabis or a placebo and measure how they feel, including withdrawal severity and drug liking. The study is very small with only 15 people, so it is a first step to see if this approach is safe and worth studying further.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
inhaled vaporized cannabis
What this could lead to
If it works, this could point toward a way to use cannabis to help manage opioid withdrawal symptoms.
What could go wrong
This is a very early, small Phase 1 trial with only 15 people. It is testing safety and basic effects, not yet a proven treatment. Results may not apply to everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Center on Drug and Alcohol Research
RECRUITINGLexington, Kentucky, 40508, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••